| Literature DB >> 35566376 |
Tingting Li1, Haiqiong Ma1, Hong Li1, Hao Tang1, Jinwen Huang1, Shiying Wei1, Qingxia Yuan1, Xiaohuo Shi2, Chenghai Gao1, Shunli Mi1, Longyan Zhao1, Shengping Zhong1, Yonghong Liu1.
Abstract
Laminaria japonica is widely consumed as a key food and medicine. Polysaccharides are one of the most plentiful constituents of this marine plant. In this study, several polysaccharide fractions with different charge numbers were obtained. Their physicochemical properties and anticoagulant activities were determined by chemical and instrumental methods. The chemical analysis showed that Laminaria japonica polysaccharides (LJPs) and the purified fractions LJP0, LJP04, LJP06, and LJP08 mainly consisted of mannose, glucuronic acid, galactose, and fucose in different mole ratios. LJP04 and LJP06 also contained minor amounts of xylose. The polysaccharide fractions eluted by higher concentration of NaCl solutions showed higher contents of uronic acid and sulfate group. Biological activity assays showed that LJPs LJP06 and LJP08 could obviously prolong the activated partial thromboplastin time (APTT), indicating that they had strong anticoagulant activity. Furthermore, we found that LJP06 exerted this activity by inhibiting intrinsic factor Xase with higher selectivity than other fractions, which may have negligible bleeding risk. The sulfate group may play an important role in the anticoagulant activity. In addition, the carboxyl group and surface morphology of these fractions may affect their anticoagulant activities. The results provide information for applications of L. japonica polysaccharides, especially LJP06 as anticoagulants in functional foods and therapeutic agents.Entities:
Keywords: Laminaria japonica; anticoagulant activity; physicochemical properties; polysaccharides
Mesh:
Substances:
Year: 2022 PMID: 35566376 PMCID: PMC9102426 DOI: 10.3390/molecules27093027
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.927
Figure 1Preparation and physicochemical characteristics of LJPs and the purified fractions. Stepwise elution curve of LJPs (A), HPGPC profiles (B), monosaccharide compositions (C), and FT-IR spectra (D).
Chemical compositions and physicochemical properties of LJPs and the purified fractions.
| Samples | Mw | Protein (%) | Fuc (%) | OSO3−/COO− | Sulfate Group (%) | Chemical Composition (Molar Ratios) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Man | GlcA | Gal | Xyl | Fuc | ||||||
| LJPs | 5.5~1212.4 | 1.3 ± 0.2 | 24.3 ± 2.5 | 2.94 | 10.4 ± 0.2 | 1 | 1.7 | 1.3 | 0.3 | 2.1 |
| LJP0 | 1073.7, 22.7 | 0.2 ± 0.2 | 26.8 ± 0.3 | 2.95 | 3.5 ± 0.2 | 1 | 1.4 | 1.3 | ND | 1.8 |
| LJP04 | 140.2, 7.8 | −1.8 ± 0.6 | 12.0 ± 0.3 | 3.06 | 3.9 ± 0.6 | 1 | 1.8 | 0.4 | 0.3 | 1.1 |
| LJP06 | 129.5 | −0.9 ± 0.6 | 18.4 ± 0.3 | 3.25 | 9.5 ± 0.1 | 1 | 2.3 | 0.7 | 0.2 | 1.1 |
| LJP08 | 73.1 | −1.1 ± 1.0 | 24.6 ± 0.7 | ND * | 15.9 ± 0.1 | 1 | 2.1 | 1.4 | ND | 2.0 |
* ND: Not determined.
Figure 21H NMR spectra of LJPs (A), LJP0 (B), LJP04 (C), LJP06 (D), and LJP08 (E).
Figure 313C NMR spectra of LJPs (A), LJP0 (B), LJP04 (C), and LJP06 (D).
Figure 4SEM images of the purified fractions LJP0 (A), LJP04 (B), LJP06 (C), and LJP08 (D). The magnification is 2 kX, and the scale bar is 4 μm.
Anticoagulant activity of LJPs LJP0, LJP04, LJP06, and LJP08 (n = 3).
| Sample | APTT a | TT a | PT a | Anti-FXase b |
|---|---|---|---|---|
| Heparin | 1.22 ± 0.19 | 0.43 ± 0.16 | 0.97 ± 0.08 | 8.30 ± 0.82 |
| LMWH | 3.96 ± 0.13 | 2.15 ± 0.09 | >200 | 29.92 ± 3.50 |
| LJPs | 13.36 ± 0.82 | 12.48 ± 1.43 | >200 | 27.6 ± 4.7 |
| LJP0 | >200 | >200 | >200 | / c |
| LJP04 | 169.83 ± 23.01 | >200 | >200 | / |
| LJP06 | 18.96 ± 4.33 | 65.77 ± 8.11 | >200 | 24.9 ± 1.9 |
| LJP08 | 17.90 ± 2.50 | 3.84 ± 0.80 | >200 | 30.2 ± 4.3 |
a, The concentration required to double the APTT, TT, or PT of standard human plasma; b, EC50, the concentration of each sample required to inhibit 50% of activity; c, Not determined.